SYNIMMUNE Competitors and Similar CompaniesClear all
AnaptysBio's competitors and similar companies include Allogene Therapeutics.
 AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | |
Founding Date | Founding Date 2005 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ San Diego, US | Locations South San Francisco, US HQ |
Employees | Employees 898% decrease | Employees 2263% decrease |
Valuation ($) | Valuation ($) 930.2 m | Valuation ($) 585.5 m |
Funding | ||
Total funding raised | Total funding raised $ 83.9m | Total funding raised $ 532m |
For sources of this data, please see the company profile
View Company Profiles
Allogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company